Mobilization of healthy donors with plerixafor affects the cellular composition of T-cell receptor (TCR)-αβ/CD19-depleted haploidentical stem cell grafts

BACKGROUND: HLA-haploidentical hematopoietic stem cell transplantation (HSCT) is suitable for patients lacking related or unrelated HLA-matched donors. Herein, we investigated whether plerixafor (MZ), as an adjunct to G-CSF, facilitated the collection of mega-doses of hematopoietic stem cells (HSC)...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Rutella, Sergio, Filippini, Perla, Bertaina, Valentina, Li Pira, Giuseppina, Altomare, Lidia, Ceccarelli, Stefano, Brescia, Letizia P, Lucarelli, Barbarella, Girolami, Elia, Conflitti, Gianpiero, Cefalo, Maria Giuseppina, Bertaina, Alice, Corsetti, Tiziana, Moretta, Lorenzo, Locatelli, Franco
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2014
Matèries:
Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4158047/
https://ncbi.nlm.nih.gov/pubmed/25179788
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12967-014-0240-z
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars